Published • loading... • Updated
Federal Agencies Open Investigation Into the Safety of Abortion Drug Mifepristone ✅
The FDA review follows pressure from 22 Republican-led states amid disputes over mifepristone’s safety, used in nearly two-thirds of U.S. abortions, officials said.
- Last week, Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary announced the FDA will conduct its own review of the evidence on mifepristone's safety and efficacy.
- By citing a non-peer-reviewed EPPC analysis, critics urged restoring REMS and 2011-era safety regulations after nearly 11% reported serious adverse events versus the FDA's 0.5% rate.
- The FDA says mifepristone is safe when used as directed, reporting 36 deaths through Dec. 31, 2024, and noting five deaths per 1 million users since its 2000 approval and 2016 extension.
- Reimposing REMS would likely end teleprescribing and mailing, which now account for more than 60% of abortions and affect patients in states with abortion bans.
- Medical groups countered that mifepristone is safe, with Mini Timmaraju saying it is 'safe, effective, and essential' while Kiki Freedman warned the review could 'undermine access' and called it politically motivated.
Insights by Ground AI
Podcasts & Opinions
78 Articles
78 Articles
Abortion drug review, Starbucks closures, tropical tango for hurricanes: Check out today’s news stories | News Channel 3-12
By Sarah Hutter, CNN Welcome to 5 Things PM! If you’re a parent or guardian, you’ve likely heard about the importance of respecting your children’s feelings. But to raise emotionally healthy kids, your mental health needs to matter, too. Here’s what else you might have missed during your busy day. 5 things 1⃣ Approved drug questioned The FDA is reviewing evidence about the safety and efficacy of mifepristone — used in medication abortion — to in…
MedPage TodayReposted by 
Anti-Aging, Acupuncture and Health News
Anti-Aging, Acupuncture and Health NewsFDA to Launch Review of Abortion Pill Safety
(MedPage Today) -- The Trump administration said it will review the medication abortion drug mifepristone (Mifeprex) to see whether current restrictions on its use are sufficient to keep patients safe. "Since its original approval, the FDA has...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources78
Leaning Left10Leaning Right9Center52Last UpdatedBias Distribution73% Center
Bias Distribution
- 73% of the sources are Center
73% Center
14%
C 73%
13%
Factuality
To view factuality data please Upgrade to Premium
